戻る
Akeso, Inc. (09926.HK)価格
09926.HK 株価推移チャート
AKESO (09926.HK)
Akeso, Inc.
HK$104.3
-2.34%
$-2.5
レギュラーマーケット： Feb 16, 09:47:43 HKT
主要データ
前終値
$105.3
始値
$106.8
当日レンジ
$104.3 - $106.8
52週レンジ
$55.65 - $179
取引高
30.1K
平均取引高
6.0M
1株当たり利益(TTM)
-1.08
配当利回り
--
時価総額
$96.0B
AKESOとは何ですか？
Akeso, Inc. Is an investment company, which engages in the research and development, production, and sale of biopharmaceuticals products. The company is headquartered in Zhongshan, Guangdong and currently employs 3,529 full-time employees. The company went IPO on 2020-04-24. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The firm's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.